DMD #44016
3
ABSTRACT:
Cytochrome P450 2A13 (CYP2A13) has been identified as an efficient catalyst for the metabolisms of coumarin, aflatoxin B 1 (AFB 1 ), and several tobacco-specific carcinogens. The reported CYP2A13 polymorphisms with missense variations have been studied for their functional consequences, and CYP2A13*4 (R101Q) variant was found to be a null enzyme in metabolizing 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), AFB 1 and 5-methoxypsoralen. In the present study, CYP2A13*4 was expressed in Sf9 cells and evaluated for coumarin 7-hydroxylation activity. Our results demonstrated that CYP2A13*4
showed no activity in coumarin 7-hydroxylation. Furthermore, computer modeling studies were conducted to probe the mechanisms underlying the loss of catalytic activity of CYP2A13*4. The results suggested that the R101Q alteration may result in the absence of several hydrogen bonds involved in heme binding and thus lead to the loss of function in CYP2A13*4. In addition, for the first time, the distribution frequencies of all eight known CYP2A13 missense alleles were examined in a Chinese Han population. The distribution frequencies of CYP2A13*3 allele and CYP2A13*4 allele in the Chinese Han population were statistically significantly different from the reported values in Japanese. Considering that the two variants of CYP2A13 are incapable of metabolic activation of NNK and AFB 1 , the susceptibility to NNK or AFB 1 exposure between the Chinese Han population and Japanese can be different.
Introduction
CYP2A13 is a member of the human CYP2A subfamily (Fernandez-Salguero and Gonzalez, 1995) and predominantly expressed in human respiratory tract (Su et al., 2000) .
Previous studies demonstrated that CYP2A13 plays an important role in the metabolic activation of some toxicants and carcinogens such as hexamethylphosphoramide, N,N-dimethylaniline, and Nnitrosomethyl-phenylamine (Zhang et al., 2002) , and is especially highly efficient in AFB 1 and NNK activation Jalas et al., 2005) . It is expected that CYP2A13 would be involved in the carcinogenicity and toxicity exerted by these carcinogens.
Nine non-synonymous single-nucleotide polymorphisms (SNPs) have been identified for human CYP2A13, including an insertional frame-shift mutation (133_134T insertion, CYP2A13*3) and a substitution of a stop codon (R101X, CYP2A13*7) (Cauffiez et al., 2004 (Cauffiez et al., , 2005 Cheng et al., 2004; Fujieda et al., 2003; Zhang et al., 2002 Zhang et al., , 2003 . CYP2A13*3 and CYP2A13*7 were predicted to be null in function and the other seven SNPs all result in missense variants (Table 1) . The distribution frequencies of some CYP2A13 missense alleles have been investigated in Japanese, French Caucasian and some other populations (Cauffiez et al., 2004 (Cauffiez et al., , 2005 Cheng et al., 2004; Fujieda et al., 2003; Zhang et al., 2002 Zhang et al., , 2003 . However, up to date, the distribution frequencies of all the CYP2A13 missense alleles in Chinese Han population have not yet been reported.
Among the CYP2A13 missense variants, CYP2A13*4 (R101Q) showed a loss of enzymatic activity in metabolizing NNK, AFB 1 and 5-Methoxypsoralen Goto et al., 2010) . Some characteristics of the CYP2A13*4 enzyme have been clarified in previous reports, including a loss of P450 spectrum, low electrophoretic mobility and an increased susceptibility to limited protein digestion Goto et al., 2010) .
However, the capacity of CYP2A13*4 to metabolize coumarin has not been characterized yet. Wang et al. (2006) suggested that the instability of CYP2A13*4 variant may be due to the strong interaction of the R101Q substitution with heme. Accordingly, further investigation on the interaction between the R101Q substitution and heme molecule is required.
In the present study, CYP2A13*4 variant was expressed in Sf9 cells to determine the functional consequences of R101Q substitution on coumarin 7-hydroxylation. Computer modeling studies then were conducted to probe the possible mechanisms underlying the loss of enzyme activity of CYP2A13*4. In addition, for the first time, the distribution frequencies of all eight known CYP2A13 missense alleles in a Chinese Han population were investigated.
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Materials and Methods

Materials
Polymerase chain reaction (PCR) primers were synthesized by Sangon (Shanghai, China).
PCR Enzymes were purchased from Takara (Tokyo, Japan). Mouse anti-his monoclonal antibody was purchased from GE Healthcare Bio-Sciences (Little Chalfont, Buckinghamshire, UK) and peroxidase-conjugated goat anti-mouse antibody was purchased from Zhongshan Biotechnology (Guangdong, China). Bac-to-Bac baculovirus expression system and cell culture media were purchased from Invitrogen (Calsbad, CA). Coumarin, 7-hydroxycoumarin, hemin, human NADPH-P450 reductase, NADPH, NADP+, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase were purchased from Sigma (St. Louis, MO).
Construction of CYP2A13 Variants
The CYP2A13*1 gene with a His-tag at the C-terminus was a generous gift from Dr. Hong (University of Medicine and Dentistry of New Jersey, NJ 08854, USA). Using CYP2A13*1 as template, CYP2A13*4 was generated by amplification using Pyrobest DNA Polymerase.
CYP2A13*2/*5/*6/*8/*9 were also produced and served as controls. The PCR primers for site-directed mutagenesis are shown in Supplemental Table 1 . All PCR products were sequenced to ensure that no unintended mutation was introduced.
Heterologous Expression of CYP2A13
Expression of CYP2A13 proteins was performed in BAC-to-BAC baculovirus expression system as described previously (He et al., 2004) . The microsomes were prepared as described earlier (Patten et al., 1996) and stored at -80 ºC prior to use.
Immunoblot Analysis and Determination of P450 content
This article has not been copyedited and formatted. The final version may differ from this version. Expression of each CYP2A13 variant was detected by western blot as described previously (Chen et al., 2006) . Microsomal P450 content was determined by reduced CO-difference spectrum as previously described (Omura and Sato, 1964) . The CO-difference spectra were recorded using a Jasco V-550 Spectrophotometer (Jasco, Japan).
Coumarin 7-hydroxylation
The incubation protocol was modified from a previously reported method (He et al., 2004) . Alto, CA) as previously described (Von Weymarn et al. 1999) . The flow rate was 1.4 ml/min, the column temperature was maintained at 35 ºC and chromatographic separation of 7-hydroxycoumarin was obtained by isocratic elution with 23% acetonitrile and 77% 0.01 M ammonium acetate (Sigma, St. Louis, MO). Each reaction was conducted in triplicate in three independent experiments.
Molecular Modeling
Molecular modeling studies were conducted to investigate the effects of mutation on enzymatic activity of CYP2A13*4. The initial structure of CYP2A13 was obtained from the Protein Data Bank (PDB ID: 2P85) (Smith et al., 2007) . The mutation model for CYP2A13*4
was constructed using Sybyl 6.9 (Tripos, St. Louis, MO), followed by energy-minimization using Amber10 (Case et al., 2008) . The structure of coumarin was built using Sybyl 6.9 and geometrically optimized at the HF/6-31G* level by Gaussian03 (Frisch et al., 2004) . Then, coumarin was docked into CYP2A13*1 and CYP2A13*4 using Autodock4.2 (Morris et al., 2009 ). Finally, the resulting complexes were subjected to molecular dynamics (MD)
simulations by the Amber10 software, using similar parameters as described in previous report (Li et al. 2009 ).
DNA Isolation
Two hundred healthy Chinese Han adults were recruited in this study from the clinical laboratory in the Second Affiliated Hospital of Zhejiang University. The research protocol was approved by the Ethics Committee of Zhejiang University. Genomic DNA was isolated from 2 ml blood sample drawn from each volunteer using a blood genomic DNA isolation kit (Axygen, Hangzhou, China). Samples were stored in the TE buffer (pH 8.0) at -20°C before use.
Distribution of CYP2A13 alleles in a Chinese Han Population
Two-step allele-specific amplification (ASA) was applied to mutation detection. First, using genomic DNA as template, two long fragments, F1 and F2, were amplified by 25 cycles with two pairs of CTP2A13-specific primers described previously (Supplemental Table 2 , Cauffiez et al., 2004) . PCR products from five samples were randomly chosen for sequencing and served as positive controls for the second step.
Using the PCR product of the first step as template, the second amplification was performed as described previously (Chen et al., 2006) at an optimized annealing temperature (Supplemental Table 2 ). Five sequenced samples in step 1 were used as positive controls, and 
Results and Discussion
To investigate the structural relationship between the R101Q substitution and the capacity of CYP2A13*4 to metabolize coumarin, CYP2A13*4 variant was constructed by site-directed mutagenesis and expressed in a well established Bac-to-Bac insect expression system. The other CYP2A13 missense variants (CYP2A13*2/*5/*6/*8/*9) were also expressed and served as controls. Using anti-His monoclonal antibody, protein bands around 56 KD were detected in the microsomes from all the Sf9 cells transfected with bacmids containing CYP2A13 cDNAs, except the negative control transfected with blank bacmid (Fig. 1A) . Consistent with a previous report , CYP2A13*4 protein showed a reduced expression level in sf9 cells (Fig. 1A ) and a loss of P450 spectrum (Fig. 1C ) compared with other CYP2A13
variants. Goto et al. (2010) reported that the electrophoretic mobility of the recombinant CYP2A13*4 protein in SDS-PAGE gel was slightly lower than the other recombinant CYP2A13 proteins. However, there was no obvious difference observed in electrophoretic mobility among the CYP2A13 variants in SDS-PAGE analysis in ou r study. This inconsistency might be partially due to the different expression systems and different purities of the recombinant CYP2A13 proteins and remains to be examined in future work.
Kinetic analysis was conducted for the variant and wild-type proteins using different substrate concentrations (0.5, 2, 5, 10, 15, 20 and 25 μ M). Consistent with Schlicht and colleagues' report (2007) , the CYP2A13*2/*5/*6/*8/*9 variants resulted in only modest changes in catalytic efficiency compared with CYP2A13*1. However, the kinetic parameters of CYP2A13*4 can not be determined, as there was no detectable product of coumarin
7-hydroxylation.
This article has not been copyedited and formatted. The final version may differ from this version. Computer modeling studies were then performed to probe the mechanisms underlying the loss of function of CYP2A13*4. The mutation is located within the B-B' loop and is very close to heme. Previously, Wang et al. (2006) suggested that the effect of R101Q variation on CYP2A13 may be due to its strong interaction with heme. To gain deeper insights into the mechanisms, MD simulations were carried out for both CYP2A13*1 and CYP2A13*4. CYP2A13*4 showed higher RMSD values (Fig. 2) during the simulations, which suggested larger structural deviations and less stability compared with CYP2A13*1 (consistent with the experimental result). In addition, the hydrogen-bonding interactions (Supplementary Table 3 , Fig. 3 ) at the mutation site were analyzed. From Supplementary Table 3, R to Q substitution precluded hydrogen-bonding interaction capability of heme with residue 101 and 372. Besides, the interaction between heme and residue 437 also decreased. As we know, heme is anchored by hydrogen-bonding interactions in the active site and plays an important role in electron transfer during the catalysis. Therefore, the above hydrogen-bonding network changes could greatly affect the appropriate heme binding, and further lead to the loss of the function in CYP2A13*4.
In addition to coumarin, CYP2A13*4 also showed a d ecreased metabolic activity on NNK and aflatoxin B 1 (Jalas et al., 2005; He et al., 2006) . The mechanism of such enzyme activity loss suggested that the same tendency will be also observed in metabolisms of other environmental chemicals. It is reasonable to assume that the ethnic difference in distribution of CYP2A13*4 allele may lead to the ethnic difference in the human susceptibility to some environmental chemicals. Therefore, the frequency distribution of CYP2A13*4 in a Chinese
Han population was investigated, along with the other seven CYP2A13 alleles.
To investigate the distribution frequencies of CYP2A13 alleles in a Chinese Han population, a two-step ASA method was applied to genomic DNA samples of 200 unrelated volunteers. Five DNA samples, analyzed by sequencing, were used as positive controls, and the results of ASA of the five positive controls were consistent with the results of sequencing.
The distribution of CYP2A13 polymorphisms conformed to the prediction of Hardy-Weinberg.
The frequency of CYP2A13*2 (R257C) allele, CYP2A13*3 (133_134T insertion) allele, CYP2A13*4 (R101Q) allele, CYP2A13*5 (F453Y) allele, CYP2A13*6 (R494C) allele, CYP2A13*7 (R101X) allele, CYP2A13*8 (D158E) allele and CYP2A13*9 (V323L) allele was 6.5%, 1.0%, 3.8%, 1.0%, 1.5%, 4.0%, 1.3% and 0.5%, respectively (Table 1, details in   Supplementary Table 4) .
Compared with other ethnic groups reported previously, the distribution frequencies of certain CYP2A13 alleles in the Chinese population were significantly different from that in Japanese. CYP2A13*3 allele, reported as an unstable variant (Schlicht et al. 2007 ), has a much higher frequency in Japanese (4.9%) than that in Chinese Han population (1.0%) ( p < 0.01).
CYP2A13*4 allele, which results in a null allelic variant of CYP2A13 , is distributed more widely in the Chinese Han population (3.8%) than in Japanese (0.3%) ( p < 0.01). There are no significant distribution differences of CYP2A13*7 allele, CYP2A13*8 allele and CYP2A13*9 allele between the French Caucasian (Cauffiez et al., 2004) and This article has not been copyedited and formatted. The final version may differ from this version. Frequency in other populations CYP2A13*2 R257C 6.5% 7.7% (Asian), 5.6% (Chinese), Cheng et al., 2004 5.8% (Hispanic), Cheng et al., 2004 0.0% (French Caucasians), Cauffiez et al., 2005 CYP2A13*3 133_134T insertion 1.0% 4.9% (Japanese), Fujieda et al., 2003 CYP2A13*4 R101Q 3.8% 0.3% (Japanese), Fujieda et al., 2003 3.8% (French Caucasians), Cauffiez et al., 2005 0.0% (Gabonese), 1.0% (Tunisians), Cauffiez et al., 2005 CYP2A13*5 F453Y 1.0% 0.3% (Japanese), Fujieda et al., 2003 CYP2A13*6 R494C 1.5% 1.0% (Japanese), Fujieda et al., 2003 CYP2A13*7 R101X 4.0% 5.0% (French Caucasian), Cauffiez et al., 2004 4.9% (Japanese), Fujieda et al., 2003 3.2% (Chinese), Zhang et al., 2003 CYP2A13*8 D158E 1.3% 1.0% (French Caucasian), Cauffiez et al., 2004 CYP2A13*9 V323L 0.5% 1.0% (French Caucasian), Cauffiez et al., 2004 This article has not been copyedited and formatted. The final version may differ from this version. 
